Market Overview

Sage Therapeutics (NASDAQ: SAGE)

138.47 +2.01 (1.47%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/19/18Morgan StanleyMaintainsOverweight213.0
11/15/18Leerink SwannInitiates Coverage OnUnderperform80.0
11/13/18Leerink SwannInitiates Coverage OnUnderperform80.0
11/05/18RBC CapitalMaintainsOutperform261.0
10/11/18Morgan StanleyMaintainsOverweight230.0
8/06/18PiperJaffrayInitiates Coverage OnOverweight206.0
7/13/18Morgan StanleyMaintainsOverweight228.0
6/13/18Canaccord GenuityMaintainsBuy220.0
6/06/18Ladenburg ThalmannInitiates Coverage OnBuy230.0
2/26/18Morgan StanleyInitiates Coverage OnOverweight225.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter